Back to Sites

SUNY Stony Brook

Site Number

5040

Address

SUNY Stony Brook
Health Science Center at Stony Brook
Department of Pediatric Infectious Disease
11 th Floor, Rm 031
Stony Brook, NY 11794-8111
United States of America

IMPAACT Members at this Site

Christy Beneri Co-Investigator

Kenneth D. Gadow Co-Investigator

Jennifer Griffin Co-Investigator

Michele Kelly Co-Investigator

Paul Ogburn Co-Investigator

Erin M. Infanzon CRS Coordinator

Sharon Appelbaum Nachman CRS Leader

Denise M. Ferraro Investigator

Nicole Sampson Investigator

Matthew Wipperman Investigator

Samuel Chin Pharmacist

Cristina Witzke QA/QC Coordinator

Izolda Mileva Research Assistant

Barsha Chakraborty Study Coordinator

Studies at this Site

A5257: Study of Three Compact ARV Regimens for Treatment of Naive HIV-1 Volunteers

DAIDS Number

10670

Research Area

Antiretroviral Strategies

Study Status

Concluded

1077HS: HAART Standard Version of the PROMISE Study (Maternal & Infant Survival)

DAIDS Number

10779

Research Area

Therapeutics

Study Status

Participants Off Study and Primary Analysis Completed

P1026S: PK in Pregnancy

DAIDS Number

Therapeutics

Research Area

Treatment

Study Status

Closed to Follow Up

P1066: Raltegravir Safety, Tolerability, PK, & Antiretroviral Activity

DAIDS Number

10495

Research Area

Treatment

Study Status

Concluded

P1074: IMPAACT LTFU Study

DAIDS Number

10660

Research Area

Complications & Comorbidities

Study Status

Concluded

P1080: ARV & Psychiatric Medication Concentrations in HIV Infected & Uninfected Children

DAIDS Number

10768

Research Area

Brain and Mental Health

Study Status

Closed to Follow Up

P1110: Safety and PK of RAL in Neonates

DAIDS Number

11891

Research Area

Treatment

Study Status

Concluded

P1115: Very Early Intensive Treatment of Infants Living with HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study

DAIDS Number

11954

Research Area

Cure and Immunotherapy

Study Status

Enrolling

IMPAACT 2002: Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression among Youth Living with HIV in the United States

DAIDS Number

12051

Research Area

Brain and Mental Health

Study Status

Participants Off Study and Primary Analysis Completed

IMPAACT 2011: Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID delta M2-2 1030s, Lot RSV#010A, Delivered as Nose Drops to RSV-Seronegative Infants 6 to 24 Months of Age

DAIDS Number

30072

Research Area

Complications & Comorbidities

Study Status

Concluded